373 related articles for article (PubMed ID: 24330529)
21. Changing mortality rates and causes of death for HIV-infected individuals living in Southern Alberta, Canada from 1984 to 2003.
Krentz HB; Kliewer G; Gill MJ
HIV Med; 2005 Mar; 6(2):99-106. PubMed ID: 15807715
[TBL] [Abstract][Full Text] [Related]
22. Impact of antiretroviral therapy (ART) timing on chronic immune activation/inflammation and end-organ damage.
Rajasuriar R; Wright E; Lewin SR
Curr Opin HIV AIDS; 2015 Jan; 10(1):35-42. PubMed ID: 25415420
[TBL] [Abstract][Full Text] [Related]
23. Changes in survival and causes of death among people living with HIV: Three decades of surveys from Tokyo, one of the Asian metropolitan cities.
Tsuda H; Koga M; Nojima M; Senkoji T; Kubota M; Kikuchi T; Adachi E; Ikeuchi K; Tsutsumi T; Koibuchi T; Yotsuyanagi H
J Infect Chemother; 2021 Jul; 27(7):949-956. PubMed ID: 33663931
[TBL] [Abstract][Full Text] [Related]
24. Immunologic Biomarkers, Morbidity, and Mortality in Treated HIV Infection.
Hunt PW; Lee SA; Siedner MJ
J Infect Dis; 2016 Oct; 214 Suppl 2(Suppl 2):S44-50. PubMed ID: 27625430
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoids and inflammation: implications for people living with HIV.
Costiniuk CT; Jenabian MA
AIDS; 2019 Dec; 33(15):2273-2288. PubMed ID: 31764093
[TBL] [Abstract][Full Text] [Related]
26. Clinical Outcomes during Treatment Interruptions in Human Immunodeficiency Virus-Hepatitis B Virus Co-infected Patients from Sub-Saharan Africa.
Boyd A; Houghtaling L; Moh R; Chekaraou MA; Gabillard D; Eholié SP; Anglaret X; Zoulim F; Danel C; Lacombe K; For The Anrs Trivacan And Anrs VarBVA Studies
Am J Trop Med Hyg; 2017 Dec; 97(6):1936-1942. PubMed ID: 29141712
[TBL] [Abstract][Full Text] [Related]
27. Timing of antiretroviral therapy for HIV-infected patients with cytomegalovirus retinitis: study protocol of a multi-center prospective randomized controlled trial.
He XQ; Huang YQ; Zeng YM; Qin YY; Tang SQ; Xu XL; Harypursat V; Lu YQ; Liu M; Yuan J; Chen YK
Trials; 2021 Mar; 22(1):218. PubMed ID: 33736696
[TBL] [Abstract][Full Text] [Related]
28. Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors.
Prabhu VM; Singh AK; Padwal V; Nagar V; Patil P; Patel V
Front Immunol; 2019; 10():2849. PubMed ID: 31867010
[No Abstract] [Full Text] [Related]
29. Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases.
Baker JV; Peng G; Rapkin J; Krason D; Reilly C; Cavert WP; Abrams DI; MacArthur RD; Henry K; Neaton JD;
J Acquir Immune Defic Syndr; 2008 Aug; 48(5):541-6. PubMed ID: 18645520
[TBL] [Abstract][Full Text] [Related]
30. Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.
Grund B; Baker JV; Deeks SG; Wolfson J; Wentworth D; Cozzi-Lepri A; Cohen CJ; Phillips A; Lundgren JD; Neaton JD;
PLoS One; 2016; 11(5):e0155100. PubMed ID: 27171281
[TBL] [Abstract][Full Text] [Related]
31. Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy.
Marin B; Thiébaut R; Bucher HC; Rondeau V; Costagliola D; Dorrucci M; Hamouda O; Prins M; Walker S; Porter K; Sabin C; Chêne G
AIDS; 2009 Aug; 23(13):1743-53. PubMed ID: 19571723
[TBL] [Abstract][Full Text] [Related]
32. Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in Southwestern China: a retrospective cohort study.
Huang Y; Zhou O; Zheng Z; Xu Y; Shao Y; Qin C; Qin F; Lai J; Liu H; Chen R; Ye L; Liang H; Qin X; Jiang J
AIDS Res Ther; 2020 Jul; 17(1):44. PubMed ID: 32680536
[TBL] [Abstract][Full Text] [Related]
33. Plasma levels of cytokines and chemokines and the risk of mortality in HIV-infected individuals: a case-control analysis nested in a large clinical trial.
French MA; Cozzi-Lepri A; Arduino RC; Johnson M; Achhra AC; Landay A;
AIDS; 2015 Apr; 29(7):847-51. PubMed ID: 25695873
[TBL] [Abstract][Full Text] [Related]
34. Comparison of clinical outcomes between HIV-infected patients with and without HCV co-infection in a resource-limited setting.
Than NN; Sungkanuparph S; Maek-A-Nantawat W; Kaewkungwal J; Pitisuttithum P
Southeast Asian J Trop Med Public Health; 2012 May; 43(3):646-51. PubMed ID: 23077844
[TBL] [Abstract][Full Text] [Related]
35. Residual immune dysregulation syndrome in treated HIV infection.
Lederman MM; Funderburg NT; Sekaly RP; Klatt NR; Hunt PW
Adv Immunol; 2013; 119():51-83. PubMed ID: 23886064
[TBL] [Abstract][Full Text] [Related]
36. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
Panel de expertos de Gesida y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
[TBL] [Abstract][Full Text] [Related]
37. Current status of HIV/AIDS in the ART era.
Yoshimura K
J Infect Chemother; 2017 Jan; 23(1):12-16. PubMed ID: 27825722
[TBL] [Abstract][Full Text] [Related]
38. Applications and limitations of inflammatory biomarkers for studies on neurocognitive impairment in HIV infection.
Cassol E; Misra V; Morgello S; Gabuzda D
J Neuroimmune Pharmacol; 2013 Dec; 8(5):1087-97. PubMed ID: 24259252
[TBL] [Abstract][Full Text] [Related]
39. Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
; Judd A; Chappell E; Turkova A; Le Coeur S; Noguera-Julian A; Goetghebuer T; Doerholt K; Galli L; Pajkrt D; Marques L; Collins IJ; Gibb DM; González Tome MI; Navarro M; Warszawski J; Königs C; Spoulou V; Prata F; Chiappini E; Naver L; Giaquinto C; Thorne C; Marczynska M; Okhonskaia L; Posfay-Barbe K; Ounchanum P; Techakunakorn P; Kiseleva G; Malyuta R; Volokha A; Ene L; Goodall R
PLoS Med; 2018 Jan; 15(1):e1002491. PubMed ID: 29381702
[TBL] [Abstract][Full Text] [Related]
40. Antiretroviral Treatment Efficacy and Safety in Older HIV-Infected Adults.
Jourjy J; Dahl K; Huesgen E
Pharmacotherapy; 2015 Dec; 35(12):1140-51. PubMed ID: 26684554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
